ArticleNPJ science of food2025
Sustainable repeated-batch fermentation of immobilized Ganoderma formosanum for enhanced production of anti-melanogenic bioactive compounds.
Article in NPJ science of food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tyrosinase Inhibitors With Enhanced Potency in Mammalian and Vertebrate Models, N-(2-Mercaptoethyl)benzamide Derivatives: Design, Synthesis, and Evaluation.Chemical biology & drug design · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Ganoderma formosanum, an edible medicinal fungus renowned for its bioactive metabolites, faces challenges in traditional cultivation due to prolonged timelines and elevated costs, hindering its integration into functional food formulations. This study introduces an innovative, sustainable fermentation platform by immobilizing G. formosanum mycelia (GFM) on plastic composite support (PCS) within an airlift bioreactor, utilizing agricultural byproducts to foster eco-efficient production of natural anti-melanogenesis compounds with potential as functional food ingredients. Initial shake-flask evaluations identified the SY-PCS matrix, comprising soybean hulls, polypropylene, and yeast extract, as optimal for mycelial immobilization, yielding anti-melanin activity equivalent to 79.78% of kojic acid (KA) efficacy. Upscaling to a 5 L bioreactor with 1% SY-PCS supplementation on day 8 elevated this to 81.7% of KA's potency, while repeated-batch fermentation amplified second-batch biomass productivity by 2.7-fold, promoting resource-efficient yields suitable for food-grade applications. Cell-based assays in B16-F10 models demonstrated potent suppression of intracellular melanin accumulation, akin to KA, and zebrafish trials revealed a 31% reduction in melanin content. LC-MS/MS analysis identified 15 bioactive compounds, corroborated by molecular docking studies showing enhanced tyrosinase-binding affinities and synergistic effects, underscoring their promise as natural additives in functional foods for skin health support.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.